AstraZeneca Readies New Portfolio of Targeted Cancer Therapies AstraZeneca Readies New Portfolio of Targeted Cancer Therapies · The Wall Street Journal · Hector Retamal/Agence France-Presse/Getty Images Adrià Calatayud Sun, October 25, 2026 at 8:12 PM EDT 3 min read AZN 4568.T AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market. Continue Reading Terms and Privacy Policy Your Privacy Choices More Info
